Fortschr Röntgenstr
DOI: 10.1055/s-0043-118128
Urogenital Tract
© Georg Thieme Verlag KG Stuttgart · New York

Current Utilization and Acceptance of Multiparametric MRI in the Diagnosis of Prostate Cancer. A Regional Survey

Article in several languages: English | deutschTim Ullrich1, Lars Schimmöller1, Mathias Oymanns1, Dirk Blondin1, Frederic Dietzel1, Julian Kirchner1, Christian Arsov2, Robert Rabenalt2, Peter Albers2, Gerald Antoch1, Michael Quentin1
  • 1University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany
  • 2University Dusseldorf, Medical Faculty, Department of Urology, Dusseldorf, Germany
Further Information

Publication History

27 November 2016

25 July 2017

Publication Date:
21 September 2017 (eFirst)

Abstract

Purpose To assess the current regional acceptance, valuation, and clinical role of multiparametric MRI (mp-MRI) in prostate cancer diagnostics by patients and physicians.

Materials and Methods Of 482 distributed standardized questionnaires, 328 patient and 31 physician questionnaires (urological and general practitioners in and around Düsseldorf) were analyzed over a period of 11 months. Questions were asked concerning general knowledge about prostate cancer, current diagnostic procedures, and knowledge about mp-MRI and MRI-guided biopsy.

Results 70 % of the patients regarded accurate and exact diagnostics of prostate carcinomas as very important and 68 % considered MP-MRI a useful technique. 28 % of the patients with elevated PSA levels and negative transrectal ultrasound-guided biopsy (TRUS-GB) received MP-MRI as a secondary diagnostic. More than half of the patients estimated their overall knowledge about prostate cancer mediocre or worse and wished for more information about MR diagnostics. The majority of physicians (55 %) ordered MP-MRI studies of the prostate and 68 % saw their basic role in secondary diagnostics.

Conclusion In this regional assessment mp-MRI of the prostate was considered useful by patients and practitioners. Currently, there still is a considerable discrepancy between recommended and the actual number of conducted MP-MRI studies, particularly in patients after previous negative TRUS-GB, although practitioners already see the benefit in this patient collective. Even though the use of prostate MRI is frequently more established than suggested in the current German S3-guideline, its full potential has not yet been exploited. More comprehensive information about the applications and diagnostic benefits of prostate MRI is needed and desired among patients and physicians.

Key Points

  • The use of prostate MRI is frequently more established than suggested in the current German S3-guideline (12/2016)

  • The full potential of mp-MRI of the prostate has not been exploited

  • More information about the clinical benefit and potential of prostate MRI is necessary and desired by patients and clinicians

Citation Format

  • Ullrich T, Schimmöller L, Oymanns M et al. Current Utilization and Acceptance of Multiparametric MRI in the Diagnosis of Prostate Cancer. A Regional Survey. Fortschr Röntgenstr 2017; DOI: 10.1055/s-0043-118128